330 related articles for article (PubMed ID: 26613360)
1. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.
Bérard A; Iessa N; Chaabane S; Muanda FT; Boukhris T; Zhao JP
Br J Clin Pharmacol; 2016 Apr; 81(4):589-604. PubMed ID: 26613360
[TBL] [Abstract][Full Text] [Related]
2. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
Bérard A; Ramos E; Rey E; Blais L; St-André M; Oraichi D
Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):18-27. PubMed ID: 17187388
[TBL] [Abstract][Full Text] [Related]
3. SSRI antidepressants and birth defects.
Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births.
Gao SY; Wu QJ; Sun C; Zhang TN; Shen ZQ; Liu CX; Gong TT; Xu X; Ji C; Huang DH; Chang Q; Zhao YH
BMC Med; 2018 Nov; 16(1):205. PubMed ID: 30415641
[TBL] [Abstract][Full Text] [Related]
5. First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.
Wurst KE; Poole C; Ephross SA; Olshan AF
Birth Defects Res A Clin Mol Teratol; 2010 Mar; 88(3):159-70. PubMed ID: 19739149
[TBL] [Abstract][Full Text] [Related]
6. Does paroxetine cause cardiac malformations?
O'Brien L; Einarson TR; Sarkar M; Einarson A; Koren G
J Obstet Gynaecol Can; 2008 Aug; 30(8):696-701. PubMed ID: 18786292
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
Diav-Citrin O; Shechtman S; Weinbaum D; Wajnberg R; Avgil M; Di Gianantonio E; Clementi M; Weber-Schoendorfer C; Schaefer C; Ornoy A
Br J Clin Pharmacol; 2008 Nov; 66(5):695-705. PubMed ID: 18754846
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
Gentile S; Bellantuono C
J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
[TBL] [Abstract][Full Text] [Related]
9. Counseling pregnant women treated with paroxetine. Concern about cardiac malformations.
Einarson A; Koren G
Can Fam Physician; 2006 May; 52(5):593-4. PubMed ID: 16739830
[TBL] [Abstract][Full Text] [Related]
10. Paroxetine exposure during pregnancy and the risk of cardiac malformations: what is the evidence?
Bérard A
Birth Defects Res A Clin Mol Teratol; 2010 Mar; 88(3):171-4. PubMed ID: 19950383
[No Abstract] [Full Text] [Related]
11. Paroxetine use in pregnancy and increased risk of heart defects: Evaluating the evidence.
Einarson A
Can Fam Physician; 2010 Aug; 56(8):767-8. PubMed ID: 20705881
[TBL] [Abstract][Full Text] [Related]
12. Paroxetine exposure during pregnancy and cardiac malformations.
Scialli AR
Birth Defects Res A Clin Mol Teratol; 2010 Mar; 88(3):175-7. PubMed ID: 20175190
[No Abstract] [Full Text] [Related]
13. Selective serotonin reuptake inhibitors and risk for major congenital anomalies.
Malm H; Artama M; Gissler M; Ritvanen A
Obstet Gynecol; 2011 Jul; 118(1):111-120. PubMed ID: 21646927
[TBL] [Abstract][Full Text] [Related]
14. Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies.
Shen ZQ; Gao SY; Li SX; Zhang TN; Liu CX; Lv HC; Zhang Y; Gong TT; Xu X; Ji C; Wu QJ; Li D
Br J Clin Pharmacol; 2017 Apr; 83(4):909-922. PubMed ID: 27770542
[TBL] [Abstract][Full Text] [Related]
15. First trimester exposure to paroxetine and prevalence of cardiac defects: Meta-analysis of the literature: Unfortunately incomplete.
Einarson A; Koren G
Birth Defects Res A Clin Mol Teratol; 2010 Jul; 88(7):588; author reply 589. PubMed ID: 20602457
[No Abstract] [Full Text] [Related]
16. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
Bar-Oz B; Einarson T; Einarson A; Boskovic R; O'Brien L; Malm H; Bérard A; Koren G
Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
Bérard A; Zhao JP; Sheehy O
BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
[TBL] [Abstract][Full Text] [Related]
18. Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations.
Myles N; Newall H; Ward H; Large M
Aust N Z J Psychiatry; 2013 Nov; 47(11):1002-12. PubMed ID: 23761574
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant use in pregnancy and the risk of cardiac defects.
Huybrechts KF; Palmsten K; Avorn J; Cohen LS; Holmes LB; Franklin JM; Mogun H; Levin R; Kowal M; Setoguchi S; Hernández-Díaz S
N Engl J Med; 2014 Jun; 370(25):2397-407. PubMed ID: 24941178
[TBL] [Abstract][Full Text] [Related]
20. Sertraline use during pregnancy and the risk of major malformations.
Bérard A; Zhao JP; Sheehy O
Am J Obstet Gynecol; 2015 Jun; 212(6):795.e1-795.e12. PubMed ID: 25637841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
